Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.
- DOI
- 10.1093/oncolo/oyae037
- Published
- 2024 Jul 5
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyae037,
title = {Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.},
author = {Johns AC and Campbell MT and Gao M and Hahn AW and Lim Z and Wang E and Gao J and Shah AY and Msaouel P and Tannir NM},
year = {2024},
journal = {The oncologist},
doi = {10.1093/oncolo/oyae037},
url = {https://doi.org/10.1093/oncolo/oyae037}
}RIS
TY - JOUR TI - Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. AU - Johns AC AU - Campbell MT AU - Gao M AU - Hahn AW AU - Lim Z AU - Wang E AU - Gao J AU - Shah AY AU - Msaouel P AU - Tannir NM PY - 2024 JO - The oncologist DO - 10.1093/oncolo/oyae037 UR - https://doi.org/10.1093/oncolo/oyae037 ER -
APA
AC, J., MT, C., M, G., AW, H., Z, L., E, W., J, G., AY, S., P, M., & NM, T. (2024). Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.. The oncologist. https://doi.org/10.1093/oncolo/oyae037
Source records
- pubmed · retrieved 2026-09-26T16:09:39.223Z